Form 8-K - Current report:
SEC Accession No. 0000059478-22-000138
Filing Date
2022-05-04
Accepted
2022-05-04 15:04:13
Documents
15
Period of Report
2022-05-02
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lly-20220502.htm   iXBRL 8-K 105658
2 EX-3.1 articlesofincorporationlly.htm EX-3.1 74501
3 EX-3.2 bylaws.htm EX-3.2 299235
  Complete submission text file 0000059478-22-000138.txt   803133

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lly-20220502.xsd EX-101.SCH 4621
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lly-20220502_def.xml EX-101.DEF 20272
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lly-20220502_lab.xml EX-101.LAB 43313
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lly-20220502_pre.xml EX-101.PRE 21500
9 EXTRACTED XBRL INSTANCE DOCUMENT lly-20220502_htm.xml XML 31886
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

EIN.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06351 | Film No.: 22891156
SIC: 2834 Pharmaceutical Preparations